Similar articles for PMID: 31262923

Year	Number of Results
1998	1
1999	1
2002	1
2003	1
2006	2
2007	6
2008	6
2009	8
2010	6
2011	2
2012	4
2013	5
2014	7
2015	5
2016	6
2017	8
2018	13
2019	12
2020	12
2021	13
2022	20
2023	1
2024	0

1

S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal Carcinoma.

Ito T, Honma Y, Hirano H, Shoji H, Okita N, Iwasa S, Takashima A, Kato K, Boku N. Ito T, et al. Anticancer Res. 2019 Jul;39(7):3931-3936. doi: 10.21873/anticanres.13545. Anticancer Res. 2019. PMID: 31262923

2

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial.

Huang J, Xu B, Liu Y, Huang J, Lu P, Ba Y, Wu L, Bai Y, Zhang S, Feng J, Cheng Y, Li J, Wen L, Yuan X, Ma C, Hu C, Fan Q, Wang X. Huang J, et al. Cancer Commun (Lond). 2019 Apr 2;39(1):16. doi: 10.1186/s40880-019-0359-7. Cancer Commun (Lond). 2019. PMID: 30940189 Free PMC article. Clinical Trial.

3

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma.

Zhao J, Lei J, Yu J, Zhang C, Song X, Zhang N, Wang Y, Zhang S. Zhao J, et al. Invest New Drugs. 2020 Apr;38(2):500-506. doi: 10.1007/s10637-019-00866-5. Epub 2019 Oct 24. Invest New Drugs. 2020. PMID: 31650447 Free PMC article. Clinical Trial.

4

S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinoma.

Akutsu Y, Kono T, Uesato M, Hoshino I, Narushima K, Hanaoka T, Tochigi T, Semba Y, Qin W, Matsubara H. Akutsu Y, et al. Oncology. 2013;84(5):305-10. doi: 10.1159/000348294. Epub 2013 Apr 12. Oncology. 2013. PMID: 23595163

5

Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma.

Sun S, Yu H, Wang H, Zhang H, Wu X, Wang J, Chang J. Sun S, et al. Oncol Res Treat. 2019;42(3):115-122. doi: 10.1159/000495700. Epub 2019 Feb 23. Oncol Res Treat. 2019. PMID: 30799403 Clinical Trial.

6

Significance of chemotherapy-free interval and tumor regression grade in patients with recurrent esophageal squamous cell carcinoma receiving chemotherapy with fluorouracil and platinum after esophagectomy following preoperative chemotherapy.

Okunaka M, Kotani D, Demachi K, Fujiwara H, Sakashita S, Yoshino T, Fujita T, Kojima T. Okunaka M, et al. Esophagus. 2022 Apr;19(2):240-249. doi: 10.1007/s10388-021-00885-3. Epub 2021 Oct 5. Esophagus. 2022. PMID: 34611830 Free PMC article.

7

S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.

Yokota T, Onozawa Y, Boku N, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H. Yokota T, et al. Jpn J Clin Oncol. 2011 Dec;41(12):1351-7. doi: 10.1093/jjco/hyr147. Epub 2011 Oct 5. Jpn J Clin Oncol. 2011. PMID: 21980053

8

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.

Wang HY, Yao ZH, Tang H, Zhao Y, Jin SL, Zhou WP, Yao SN, Yang SJ, Liu YY, Luo SX. Wang HY, et al. Oncotarget. 2017 Jan 31;8(5):7540-7547. doi: 10.18632/oncotarget.13602. Oncotarget. 2017. PMID: 27902478 Free PMC article.

9

An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.

Kanda M, Koike M, Iwata N, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Nakayama G, Kodera Y. Kanda M, et al. Oncologist. 2020 Nov;25(11):e1650-e1654. doi: 10.1634/theoncologist.2020-0546. Epub 2020 Jul 7. Oncologist. 2020. PMID: 32557987 Free PMC article. Clinical Trial.

10

A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma.

Hiramoto S, Kato K, Shoji H, Okita N, Takashima A, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Shimada Y, Boku N. Hiramoto S, et al. Int J Clin Oncol. 2018 Jun;23(3):466-472. doi: 10.1007/s10147-018-1239-x. Epub 2018 Jan 20. Int J Clin Oncol. 2018. PMID: 29353337 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year